SCHEMBL24304268

SCHEMBL24304268

CCCCCCCCCCCCCCOC(=O)CCN(CCCCC(=O)O)CCC(=O)OCCCCCCCCCCCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGKA P23743 1/20 0.54
▸ DNM1 Q05193 1/20 0.54
▸ KDM5A P29375 2/20 0.52
▸ PHF8 Q9UPP1 2/20 0.52
▸ KDM4C Q9H3R0 1/20 0.52
▸ GPR84 Q9NQS5 7/20 0.52
▸ PPARG P37231 7/20 0.52
▸ PPARD Q03181 7/20 0.52
▸ PPARA Q07869 7/20 0.52
▸ HDAC11 Q96DB2 5/20 0.52
▸ TSHR P16473 4/20 0.52
▸ PTPN1 P18031 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ TLR2 O60603 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ FABP4 P15090 2/20 0.52
▸ SLC22A6 Q4U2R8 1/20 0.52
▸ SLC22A8 Q8TCC7 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ ESR1 P03372 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24304809 1.00 DGKA (0.54) DGKADNM1KDM5APHF8KDM4C
SCHEMBL15044736 1.00 DGKA (0.54) DGKADNM1KDM5APHF8KDM4C
SCHEMBL24305234 1.00 DGKA (0.54) DGKADNM1KDM5APHF8KDM4C
SCHEMBL23903371 0.95 NAAA (0.51) DGKADNM1GPR84PPARGPPARD
SCHEMBL23903378 0.95 NAAA (0.51) DGKADNM1GPR84PPARGPPARD
SCHEMBL25626482 0.94 DGKA (0.59) DGKADNM1KDM5APHF8KDM4C
SCHEMBL27329950 0.92 NAAA (0.58) DGKADNM1TSHRALDH1A1NAAA
SCHEMBL27329949 0.92 NAAA (0.58) DGKADNM1TSHRALDH1A1NAAA
SCHEMBL19032431 0.91 DGKA (0.54) DGKADNM1KDM5APHF8KDM4C
SCHEMBL19032457 0.91 DGKA (0.59) DGKADNM1KDM5APHF8KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357166-A1 PIPERAZINE-BASED CATIONIC LIPIDS TRANSLATE BIO, INC. 2023-11-09 — — US disclosed
US-20230357166-A1 PIPERAZINE-BASED CATIONIC LIPIDS TRANSLATE BIO, INC. 2023-11-09 — — US disclosed
WO-2023178167-A1 ASYMMETRIC PIPERAZINE-BASED CATIONIC LIPIDS TRANSLATE BIO, INC. (US) 2023-09-21 — — WO disclosed
WO-2022066916-A1 PIPERAZINE-BASED CATIONIC LIPIDS TRANSLATE BIO, INC. (US) 2022-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357166-A1 PIPERAZINE-BASED CATIONIC LIPIDS NPC1L1, SREBF2, NPC1 DGKA 1007/4885DNM1 673/4885KDM5A 2386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback